News Focus
News Focus
Followers 49
Posts 5473
Boards Moderated 0
Alias Born 04/30/2005

Re: Guzzi62 post# 333311

Wednesday, 10/20/2021 9:29:47 AM

Wednesday, October 20, 2021 9:29:47 AM

Post# of 518983
From your post: "Perhaps not all may hold true; it's been about 7 months since I have reviewed AVXL. For the record, I am not saying I don't give AVXL's approach a chance, look at their Parkinson's data."

7 months is a long time to make a such a negative statement about Anavex.

*******************************************************************************************

Here's a quote from TGD at the H.C. Wainwright 23rd Annual Global Investment Conference last month...at the 12:40 minute mark:

"But the most important distinction of A2-73 and the entire platform of sigma-1 activation is that we've now been able to learn, very recently, that sigma-1 activation goes even further upstream into the nucleus...and its been able to show that it prevents cellular stress before and after RNA translation.

So in regards to that, chromatin remodeling is restored, as well as post-translation proteins - which are toxic - are prevented, by preventing toxic RNA to be expressed into toxic proteins. So only healthy proteins are expressed by expressing healthy RNA".



https://journey.ct.events/view/48684630-6af2-4c12-a206-f94233cde440
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News